← Directory

RTW Investments

PE / VC · New York · United States

Address
New York, New York
Email
Website
LinkedIn
Founded
2010
AUM
$8 800 M
Ticket
$10-50 m

Stages

Series ASeedPre-seedSeries BLate Stage (Series C+)

Investment region

EuropeNorth AmericaAsia

Industries

MedTechHealthTechBiotechnologyHealthcare ServicesPharmaceuticalsLife Sciences

Profile

RTW Investments is a life science investment and innovation firm based in New York City. Founded by a team of doctors, academics, venture capitalists, and drug developers, RTW focuses on advancing biotech and medtech innovations. The firm is distinguished by its integration of scientific expertise with investment acumen, assembled from seasoned investment bankers, experienced lawyers, and data scientists, to build successful life sciences companies around transformative ideas. The firm invests across the full lifecycle of companies, from early-stage angel investments to public, multi-product companies. RTW specializes in the life sciences sector, with sub-sectors including biotechnology, medtech, and health tech. Their portfolio spans molecules managed by their own scientists to companies close to IPO. RTW emphasizes long-term relationships with its partner companies, going beyond financial support to offer scientific and management expertise. Notable investments by RTW include Artiva - an immunotherapy developer, C4 - protein degradation technology, Dermtech - skin cancer diagnostics, Encoded Therapeutics - genetic medicines, Jixing - biopharmaceuticals, Stoke Therapeutics - RNA-targeted medicines, Tarsus - eye-disease treatments, and Ventyx Biosciences - inflammatory disease therapeutics.

Contacts (2)

NameTitleEmailTéléphoneLinkedIn
Managing Director, Strategic Finance — — —
Venture Analyst — — —

Name, email and phone are partially hidden. Subscribe to see them in full.